Notably, while our analysis did not identify a significant correlation between MCMBP expression and genetic alterations (CNV/SNV) in PAAD, its correlation with promoter hypomethylation suggests that it could be one of the key upstream factors driving MCMBP overexpression. The gene discussed is MCMBP; the disease is pancreatic adenocarcinoma.